Sign up
Quantellect · Congress · Politician Profile

Andrew R. Garbarino Stock Trades

U.S. Representative · Republican-NY
UnknownConsumer CyclicalHealthcare

Congressional Stock Trades & Disclosures

Andrew R. Garbarino is a U.S. Representative, a Republican representing NY. As of August 2025, Quantellect has tracked 16 disclosed stock trades across 8 companies, representing $120.01K in disclosed transaction value, each filed publicly under the STOCK Act.

About Andrew R. Garbarino's congressional trading

Andrew R. Garbarino Trading Profile | Quantellect Andrew R. Garbarino Trading Profile

Andrew R. Garbarino's disclosure record shows sixteen transactions from April 2021 through August 2025, and the pattern is lopsided: four of those transactions occurred on April 23, 2021, another five occurred in June 2021 through an account identified as Andrew Roth IRA, and four more were dated October 1, 2021. After that, activity slowed sharply. Since 2022 there have been just three transactions total, the most recent a sale of Gap, Inc. shares transacted and disclosed on August 21, 2025.

The congressman represents New York's 2nd District and sits in the House as a Republican. His trading record, drawn from official disclosures filed with the Clerk of the House, spans April 2021 through August 2025 and totals 16 transactions: 6 purchases and 10 sales.

A front-loaded record with a long quiet stretch

The shape of Garbarino's disclosure history is notable mainly for its concentration. Of the 16 transactions on file, 13 occurred in 2021 alone, with 5 purchases and 8 sales that year. Two more transactions followed in 2022, split evenly between a purchase and a sale. No transactions appear for 2023 or 2024, followed by a single sale in 2025. There is no continuous trading pattern here to describe as habitual; instead, the data shows a burst of activity in 2021 followed by a much quieter disclosure record.

All 16 transactions in the disclosure record are attributed to Garbarino himself, with no spousal, dependent-child, or joint transactions appearing in the supplied data.

The June 2021 cluster is worth isolating because it reads differently from the rest. Five transactions dated June 3 and June 7, 2021, identify Andrew Roth IRA as the associated account and involve mutual funds rather than individual stocks: a purchase of a fund labeled VMCCX, and sales of funds described in the filing as Capital World Grow and Income, New Perspective (ANWPX), Investment Company of America (AIVSX), and New World (NEWFX). Four of the sales were dated June 3, while the VMCCX purchase was dated June 7. All five were disclosed on July 9, 2021. The account identification and instrument types distinguish this cluster from the individual-stock transactions disclosed elsewhere in the record.

The other eight transactions from 2021, along with the two transactions from 2022 and the single 2025 transaction, involve individual stocks.

Most frequently disclosed securities

Oramed Pharmaceuticals Inc (ORMP) is the most frequently disclosed security in Garbarino's record, appearing in 3 transactions: one purchase and two sales. The transactions were dated April 23, 2021, October 1, 2021, and January 14, 2022; their respective disclosure dates were May 24, 2021, November 3, 2021, and January 14, 2022. Oramed develops pharmaceutical solutions using a technology platform for the oral delivery of therapeutic proteins, including an oral insulin capsule identified in the supplied company description as being in Phase III clinical trials for diabetes. The description also notes license agreements involving oral vaccines for COVID-19. The company was incorporated in 2002 and is headquartered in New York.

OneSpaWorld Holdings Ltd (OSW) appears in 2 transactions, a purchase dated April 23, 2021, and a sale dated October 1, 2021. Those transactions were disclosed on May 24 and November 3, respectively. OneSpaWorld operates health and wellness centers aboard cruise ships and at destination resorts in the United States and internationally. Its services include spa and body-care treatments, fitness and personal training, nutritional consultation, hydrotherapy, and other wellness offerings. The supplied company description also identifies brands including ELEMIS and Hyperice among the products it offers.

Tellurian Inc. (TELL) also appears in 2 transactions, both purchases. The first was transacted on October 1, 2021, and disclosed on November 3, 2021; the second was both transacted and disclosed on January 14, 2022. The fact packet does not include a company description or sector classification for this entry.

Rounding out the individually tickered securities are single disclosed transactions in Bank of America Corp (BAC), a sale transacted April 23 and disclosed May 24, 2021; The Gap, Inc. under the ticker GAP, a sale transacted and disclosed August 21, 2025; a purchase reported under the ticker GPS, transacted October 1 and disclosed November 3, 2021, with no company description supplied for that entry; and a sale in Golden Star Resources, Ltd (GSS), transacted April 23 and disclosed May 24, 2021, also without a company description in the packet.

Bank of America provides financial products and services across consumer banking, wealth and investment management, global banking, and global markets. Its supplied company description includes deposit accounts, credit cards, mortgages, lending, brokerage, trust and retirement services, treasury products, underwriting, advisory services, market-making, and risk-management products. The Gap, Inc. is an apparel retailer offering products under the Old Navy, Gap, Banana Republic, and Athleta brands through stores, franchises, websites, third-party arrangements, and licensing partnerships.

Sector concentration

Where sector data is available, Garbarino's disclosed transactions split across Consumer Discretionary, with 3 transactions comprising the two OneSpaWorld entries and the 2025 GAP sale; Health Care, with 3 transactions, all involving Oramed; and Financials, with 1 transaction involving Bank of America. Nine of the 16 transactions carry no sector classification in the record. Those unclassified rows include the five mutual fund transactions, the two Tellurian purchases, the Golden Star Resources sale, and the GPS-tickered purchase. Within the seven transactions that do carry sector labels, there is no single dominant category: the activity spans consumer services and apparel retail, pharmaceutical development, and banking.

About this profile and its sourcing

This profile is built from Andrew R. Garbarino's official periodic transaction reports filed with the Clerk of the U.S. House of Representatives under the Stop Trading on Congressional Knowledge Act of 2012. Filing procedures and disclosure requirements are addressed in the House Committee on Ethics financial disclosure instruction guide. Individual reports referenced in this profile are available directly from the Clerk, including the May 24, 2021 filing covering the April 23 transactions, the July 9, 2021 filing covering the June Roth IRA transactions, the November 3, 2021 filing covering the October 1 transactions, the January 14, 2022 filing, and the August 21, 2025 filing. Disclosed amounts are reported as transaction ranges rather than exact dollar figures. This Quantellect profile is limited to publicly disclosed transaction activity. As of August 21, 2026, 276 of 537 sitting members of Congress had no disclosed trades on record, and Garbarino did not carry a published Quantellect Score because no score row existed for him at the latest published score date.

Trading activity

Trades
16
Companies
8
Disclosed Vol
$120.01K
Buys
6
38%
Sells
10
63%
Buy / Sell
0.60
ratio

Estimated trading profits

No priced buy disclosures in this window.

Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.

Where the Money Sits

share of disclosed trades · top sectors

Periodic Transaction Report filings

CompanyTypeSizeTradedEst. priceChange
GAPThe Gap, Inc.
Sell$1,001 - $15,00021 AUG 2025$20.76-2.93%
TELLTellurian Inc.
Buy$1,001 - $15,00014 JAN 2022$18.40
ORMPOramed Pharmaceuticals Inc
Sell$1,001 - $15,00014 JAN 2022$10.30-49.42%
GPSGap, Inc.
Buy$1,001 - $15,00001 OCT 2021
TELLTellurian Inc.
Buy$1,001 - $15,00001 OCT 2021$16.36
OSWOneSpaWorld Holdings Ltd
Sell$1,001 - $15,00001 OCT 2021$10.17+158.09%
ORMPOramed Pharmaceuticals Inc
Sell$1,001 - $15,00001 OCT 2021$19.51-73.30%
VMCCX [OT] F ILING S TATUS : New S UbHOLDING O F : Andrew Roth IRA L OCATION : US D ESCRIPTION : Purchase of Mutual Fund eTAIlS O fferINGS AND S IGNATure Hon. Andrew Garbarino , 07/09/2021
BuyUnknown07 JUN 2021
New World NEWFX [OT] F ILING S TATUS : New S UbHOLDING O F : Andrew Roth IRA L OCATION : US D ESCRIPTION : Sale of Mutual Fund
Sell$1,001 - $15,00003 JUN 2021
Investment Company of America AIVSX [OT] F ILING S TATUS : New S UbHOLDING O F : Andrew Roth IRA L OCATION : US D ESCRIPTION : Sale of Mutual
Sell$1,001 - $15,00003 JUN 2021
Prev1
Go to

Congressional trading news

The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.

Andrew R. Garbarino congressional trading FAQ

Can Andrew R. Garbarino legally trade stocks?

Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Andrew R. Garbarino's disclosures so the public can review them.

Where does Quantellect get Andrew R. Garbarino's trading data?

Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.

How can I track Andrew R. Garbarino's stock trades?

Quantellect tracks every stock trade Andrew R. Garbarino discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.

How many stock trades has Andrew R. Garbarino disclosed?

Quantellect has tracked 16 disclosed trades by Andrew R. Garbarino across 8 companies.

Which stocks does Andrew R. Garbarino trade most?

Andrew R. Garbarino's most frequently disclosed positions are ORMP (3 disclosed trades), OSW (2 disclosed trades), TELL (2 disclosed trades), BAC (1 disclosed trade), GAP (1 disclosed trade), and GPS (1 disclosed trade), followed by GSS. The full list of companies and individual filings is shown on this page.

Which sectors does Andrew R. Garbarino invest in?

Consumer Cyclical is the heaviest sector in Andrew R. Garbarino's classified disclosures, covering 3 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.

What was Andrew R. Garbarino's most recent stock trade?

Andrew R. Garbarino most recently sold The Gap, Inc. (GAP) in August 2025, according to public STOCK Act filings tracked by Quantellect.

What is Andrew R. Garbarino's Quantellect Score?

Andrew R. Garbarino has a directory baseline value of 10, not a measured Quantellect Score. No disclosed purchases were found in the trailing 24-month scoring window; at least 2 eligible priced purchases are required for a measured Q Score. Baseline 10 is a directory value, not a measured Q Score, and is excluded from ranking and percentile calculations.

Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview

Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.